A rare case of lethal midline granuloma posing a diagnostic challenge in COVID times and the response to chemotherapy
Journal of Dermatology and Dermatologic Surgery
; 26(3):S23-S25, 2022.
Article
in English
| EMBASE | ID: covidwho-2033232
ABSTRACT
Lethal midline granuloma is a rare aggressive, mutilating disorder of the upper airways. It is most likely secondary to natural killer/T-cell lymphoma and is difficult to diagnose owing to the varied and nonspecific symptoms. It is usually prevalent in the fourth decade of life and carries a poor prognosis. Our patient was a 19-year-old male with disease duration of 3 months, was diagnosed with lethal midline granuloma based on clinical examination, histopathology, and immunohistochemistry. The patient responded well to the first cycle of chemotherapy.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Journal of Dermatology and Dermatologic Surgery
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS